GEN Exclusives

More »

GEN News Highlights

Back to Item »

Lonza to Provide Cell-Line and Process-Development Services for Athera’s mAb

The phosphorylcholine candidate is being developed as a treatment for preventing restenosis in patients with acute coronary syndrome.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Celebrities and Genetic Testing

Do you think celebrity announcements that they took a genetic test will generally increase the odds that more members of the public will undergo genetic testing?

More »